(MRVL) Marvell Technology - Overview
Stock: Processors, Controllers, Transceivers, Adapters, DSPs
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.33% |
| Yield on Cost 5y | 0.47% |
| Yield CAGR 5y | 7.46% |
| Payout Consistency | 95.0% |
| Payout Ratio | 9.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 54.3% |
| Relative Tail Risk | -5.12% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.33 |
| Alpha | -61.38 |
| Character TTM | |
|---|---|
| Beta | 2.290 |
| Beta Downside | 2.549 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.79% |
| CAGR/Max DD | 0.37 |
Description: MRVL Marvell Technology January 28, 2026
Marvell Technology Group Ltd (NASDAQ: MRVL) designs and sells semiconductor solutions that span the data-center core to the network edge. Its product suite includes system-on-chip (SoC) architectures that combine analog, mixed-signal, and digital processing, plus a broad Ethernet portfolio (controllers, adapters, PHYs, switches), custom ASICs, and a range of interconnect technologies such as silicon-photonic transceivers, coherent DSPs, and co-packaged optics. The company also offers storage-controller and host-interface chips (SATA, SAS, PCIe, NVMe, NVMe-over-Fabrics) and Fibre Channel adapters, serving customers worldwide from the United States to Asia-Pacific.
In the latest quarter (Q2 FY2024) Marvell reported revenue of **$1.07 billion**, up **12 % YoY**, driven primarily by strong demand for its data-center Ethernet and silicon-photonic products. Gross margin improved to **53 %**, reflecting higher-margin custom ASIC wins. The data-center semiconductor market is projected to grow at a **CAGR of ~9 % through 2029**, while silicon-photonic adoption is expected to accelerate as hyperscale cloud providers seek higher bandwidth per watt.
For a deeper, data-driven view of Marvell’s valuation dynamics, you may find it worthwhile to explore the analyst tools on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 2.47b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.15 > 1.0 |
| NWC/Revenue: 35.62% < 20% (prev 19.59%; Δ 16.03% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.89b > Net Income 2.47b |
| Net Debt (3.00b) to EBITDA (4.37b): 0.69 < 3 |
| Current Ratio: 2.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (869.9m) vs 12m ago 0.49% < -2% |
| Gross Margin: 50.69% > 18% (prev 0.40%; Δ 5029 % > 0.5%) |
| Asset Turnover: 37.74% > 50% (prev 27.27%; Δ 10.48% > 0%) |
| Interest Coverage Ratio: 14.82 > 6 (EBITDA TTM 4.37b / Interest Expense TTM 207.3m) |
Altman Z'' 2.14
| A: 0.13 (Total Current Assets 5.51b - Total Current Liabilities 2.74b) / Total Assets 21.58b |
| B: 0.05 (Retained Earnings 1.01b / Total Assets 21.58b) |
| C: 0.15 (EBIT TTM 3.07b / Avg Total Assets 20.65b) |
| D: 0.13 (Book Value of Equity 1.01b / Total Liabilities 7.52b) |
| Altman-Z'' Score: 2.14 = BBB |
Beneish M -2.90
| DSRI: 1.07 (Receivables 1.55b/997.9m, Revenue 7.79b/5.38b) |
| GMI: 0.78 (GM 50.69% / 39.60%) |
| AQI: 0.86 (AQ_t 0.69 / AQ_t-1 0.81) |
| SGI: 1.45 (Revenue 7.79b / 5.38b) |
| TATA: 0.03 (NI 2.47b - CFO 1.89b) / TA 21.58b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of MRVL shares?
Over the past week, the price has changed by +1.72%, over one month by -9.01%, over three months by -13.92% and over the past year by -32.45%.
Is MRVL a buy, sell or hold?
- StrongBuy: 23
- Buy: 9
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MRVL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 116.3 | 44.8% |
| Analysts Target Price | 116.3 | 44.8% |
| ValueRay Target Price | 80.4 | 0.1% |
MRVL Fundamental Data Overview February 07, 2026
P/E Forward = 21.8341
P/S = 8.2092
P/B = 4.4774
P/EG = 1.5245
Revenue TTM = 7.79b USD
EBIT TTM = 3.07b USD
EBITDA TTM = 4.37b USD
Long Term Debt = 3.97b USD (from longTermDebt, last quarter)
Short Term Debt = 631.0m USD (from shortTermDebt, last quarter)
Debt = 5.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.00b USD (from netDebt column, last quarter)
Enterprise Value = 66.29b USD (63.98b + Debt 5.03b - CCE 2.71b)
Interest Coverage Ratio = 14.82 (Ebit TTM 3.07b / Interest Expense TTM 207.3m)
EV/FCF = 42.01x (Enterprise Value 66.29b / FCF TTM 1.58b)
FCF Yield = 2.38% (FCF TTM 1.58b / Enterprise Value 66.29b)
FCF Margin = 20.25% (FCF TTM 1.58b / Revenue TTM 7.79b)
Net Margin = 31.75% (Net Income TTM 2.47b / Revenue TTM 7.79b)
Gross Margin = 50.69% ((Revenue TTM 7.79b - Cost of Revenue TTM 3.84b) / Revenue TTM)
Gross Margin QoQ = 51.57% (prev 50.38%)
Tobins Q-Ratio = 3.07 (Enterprise Value 66.29b / Total Assets 21.58b)
Interest Expense / Debt = 1.02% (Interest Expense 51.2m / Debt 5.03b)
Taxrate = 14.18% (314.1m / 2.22b)
NOPAT = 2.64b (EBIT 3.07b * (1 - 14.18%))
Current Ratio = 2.01 (Total Current Assets 5.51b / Total Current Liabilities 2.74b)
Debt / Equity = 0.36 (Debt 5.03b / totalStockholderEquity, last quarter 14.06b)
Debt / EBITDA = 0.69 (Net Debt 3.00b / EBITDA 4.37b)
Debt / FCF = 1.90 (Net Debt 3.00b / FCF TTM 1.58b)
Total Stockholder Equity = 13.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.98% (Net Income 2.47b / Total Assets 21.58b)
RoE = 18.25% (Net Income TTM 2.47b / Total Stockholder Equity 13.55b)
RoCE = 17.53% (EBIT 3.07b / Capital Employed (Equity 13.55b + L.T.Debt 3.97b))
RoIC = 14.76% (NOPAT 2.64b / Invested Capital 17.86b)
WACC = 13.38% (E(63.98b)/V(69.01b) * Re(14.36%) + D(5.03b)/V(69.01b) * Rd(1.02%) * (1-Tc(0.14)))
Discount Rate = 14.36% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.42%
[DCF Debug] Terminal Value 63.60% ; FCFF base≈1.51b ; Y1≈1.72b ; Y5≈2.35b
Fair Price DCF = 19.27 (EV 19.35b - Net Debt 3.00b = Equity 16.35b / Shares 848.1m; r=13.38% [WACC]; 5y FCF grow 15.90% → 2.90% )
EPS Correlation: -5.76 | EPS CAGR: -48.79% | SUE: -4.0 | # QB: 0
Revenue Correlation: 60.11 | Revenue CAGR: 12.29% | SUE: 0.42 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.76 | Chg30d=-0.018 | Revisions Net=+2 | Analysts=29
EPS next Year (2027-01-31): EPS=3.51 | Chg30d=-0.056 | Revisions Net=+1 | Growth EPS=+24.8% | Growth Revenue=+22.1%